PainReform Ltd.

The momentum for this stock is not very good. Tradey thinks it is not wise to invest in PainReform Ltd..
Log in to see more information.

News

PainReform Ltd. Launches Warrant Exercise Incentive Program
PainReform Ltd. Launches Warrant Exercise Incentive Program

TipRanks Financial Blog PainReform (PRFX) has released an update. PainReform Ltd. is making a strategic inducement offer to warrant holders, providing an opportunity to purchase new warran...\n more…

PainReform confirms sutures compatibility for in trial for PRF-110
PainReform confirms sutures compatibility for in trial for PRF-110

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110

Globe Newswire Positive Compatibility Results Reinforce Safety and Efficacy of PRF-110 in Post-Surgical Pain ManagementTEL AVIV, Israel, Sept. 11, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX...\n more…

PainReform to raise $1.58M through exercise of warrants
PainReform to raise $1.58M through exercise of warrants

Seeking Alpha - Israel Stocks PainReform to raise $1.58M through exercise of warrants...\n more…

PainReform exercises warrants for $1.58M in gross proceeds
PainReform exercises warrants for $1.58M in gross proceeds

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds

Globe Newswire TEL AVIV, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation...\n more…